A curated list of prominent venture capital firms and angel groups specifically dedicated to funding high-risk, high-reward innovations in deep technology and biotechnology. These investors provide not just capital, but access to extensive scientific networks and regulatory expertise essential for long-term scientific breakthroughs.
Get targeted exposure with custom position pinning and highlighted placement.
A venture capital firm that constructs companies from the ground up in deep technology sectors like biotech, AI, and climate. They offer a unique model where they identify problems, recruit teams, and provide long-term capital, often holding investments for decades to allow for thorough scientific validation.
One of the largest global healthcare-focused investors with a strong emphasis on biotechnology and digital health. They manage multiple funds targeting early to growth-stage companies, leveraging their deep expertise in regulatory pathways and clinical development to support portfolio companies through complex validation phases.
Known for its aggressive investment strategy in deep tech and biotech, often leading early rounds for disruptive innovations. The firm is particularly active in synthetic biology, energy, and healthcare, providing capital and strategic advice to founders tackling fundamental scientific challenges with market-scale potential.
A pioneering biotechnology company focused on developing transformative gene-based medicines for serious diseases. While primarily a portfolio company, its founding and growth were heavily supported by specialized deep tech investors, making it a key reference point for the current state of gene editing commercialization.
An early-stage venture capital firm based in Colorado, specializing in deep tech startups involving advanced materials, energy, and medical technologies. They combine scientific expertise with business strategy, often supporting founders who need help navigating the long product development cycles typical of deep tech industries.
A global venture firm focusing exclusively on digital health and technology investments. They target early-stage companies leveraging data, AI, and biotech to transform healthcare delivery and treatment outcomes, offering strategic support in commercialization and partnership development within the complex healthcare ecosystem.
A venture capital firm and startup accelerator that focuses on deep technology sectors including bio, health, space, and energy. Their HAX accelerator is particularly renowned for supporting hardware-intensive deep tech startups, providing hands-on manufacturing support and access to a global network of industry experts.
An investment firm that targets fundamental breakthroughs in technology, science, and business models. They are known for investing in deep tech companies that are often overlooked by traditional venture capital, providing long-term patient capital to build enduring companies in sectors like materials science and biotech.
A venture capital firm founded by scientists, focusing on identifying and building innovative biotechnology companies from the earliest stages. Their scientist-led approach ensures deep technical diligence, and they leverage their network to help portfolio companies attract talent, secure partnerships, and navigate clinical trials.
An early-stage VC firm in Chicago, focusing on deep tech startups in healthcare, industrial tech, and digital media. They provide strategic support and access to their network of operational experts, helping founders scale technologies that address significant market inefficiencies through scientific and engineering innovations.
A global biotechnology company primarily focused on identifying and developing novel immunotherapies for the treatment of cancer and other infectious diseases. Their work in mRNA technology has highlighted the viability of deep tech approaches in biotech, attracting significant interest from specialized venture capital sources.
A venture firm focused on the science and technology of human longevity and healthspan extension. They invest in foundational deep tech companies in synthetic biology, regenerative medicine, and AI-driven drug discovery, aiming to support innovations that could significantly extend healthy human life.
The venture capital arm of Alphabet Inc., with a significant portfolio in deep tech and biotechnology. They provide capital and access to Google's technological resources, supporting startups in areas like digital health, synthetic biology, and advanced computing that intersect with machine learning and big data.
A venture capital firm investing in science and technology across healthcare, advanced technologies, and sustainability. They are particularly active in genomics and personalized medicine, providing deep expertise in regulatory strategy and clinical development to help biotech companies bring innovative therapies to market.
A venture capital firm focused on biotechnology and healthcare investments, particularly in Europe and Israel. They target early-stage companies with disruptive technologies in oncology, rare diseases, and digital health, offering strategic guidance on regulatory approvals and international expansion strategies.
A leading global venture capital firm with a strong history of investing in deep tech and biotech companies. Their healthcare practice focuses on companies leveraging technology to improve patient outcomes, providing capital and strategic support to scale innovations in diagnostics, therapeutics, and healthcare IT.
One of the largest global venture capital firms with a dedicated life sciences practice. They invest in early and growth-stage biotech and healthcare IT companies, offering extensive support in clinical trial design, regulatory strategy, and commercialization to help deep tech innovators succeed.
A prominent venture capital firm that has expanded into biotech and science, offering bio fund support for deep tech innovations. They provide operational expertise in regulatory affairs, clinical development, and data science, helping founders navigate the complex landscape of bringing scientific breakthroughs to market.
A leading venture capital firm in China specializing in biotechnology and healthcare investments. They focus on early-stage companies in genomic medicine, cell therapy, and digital health, leveraging their deep industry networks to support Chinese biotech firms in both domestic and global expansion.
The world's most prominent startup accelerator, which also supports deep tech and biotech companies through its batch program. While known for software, they increasingly back scientific startups, providing seed funding, mentorship, and access to a vast network of technical advisors and potential investors.